Marco Valgimigli Selected Research

Duration of Therapy

12/2021	Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial.
1/2021	Patient-tailored antithrombotic therapy following percutaneous coronary intervention.
11/2020	Assessment of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion: The MATRIX (minimizing adverse hemorrhagic events by transradial access site and angioX) OCT study.
1/2020	A 4-item PRECISE-DAPT score for dual antiplatelet therapy duration decision-making.
12/2019	Comparison of intra-procedural vs. post-stenting prolonged bivalirudin infusion for residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing: the MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX) OCT study.
1/2019	Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting.
1/2019	Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study.
1/2018	Real-world application of currently available decision models for dual antiplatelet therapy duration in acute coronary syndrome.
1/2018	Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
11/2017	Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Valgimigli Research Topics

Disease

179	Hemorrhage 12/2022 - 10/2009
166	Myocardial Infarction 11/2022 - 05/2004
148	Thrombosis (Thrombus) 11/2022 - 01/2005
99	Acute Coronary Syndrome 11/2022 - 07/2004
86	ST Elevation Myocardial Infarction 01/2022 - 05/2004
74	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 06/2004
64	Stroke (Strokes) 11/2022 - 05/2005
34	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 01/2005
24	Death (Near-Death Experience) 12/2021 - 05/2008
23	Atrial Fibrillation 11/2022 - 11/2014
16	Hyperplasia 11/2020 - 08/2006
13	Pathologic Constriction (Stenosis) 11/2016 - 03/2005
12	Diabetes Mellitus 11/2021 - 05/2005
10	Infarction (Infarctions) 02/2022 - 01/2007
10	Ischemia 01/2021 - 10/2010
9	Chronic Renal Insufficiency 11/2021 - 11/2012
9	Heart Failure 01/2021 - 06/2004
7	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 09/2011
7	AIDS-Related Complex (ARC) 12/2021 - 10/2013
6	Thrombocytopenia (Thrombopenia) 11/2021 - 09/2010
5	Aortic Valve Stenosis (Aortic Stenosis) 10/2022 - 06/2016
5	Hypertension (High Blood Pressure) 01/2021 - 12/2015
4	Chronic Obstructive Pulmonary Disease (COPD) 11/2022 - 01/2020
4	Unstable Angina 01/2020 - 07/2011
4	Stable Angina 09/2015 - 12/2006
3	Heart Diseases (Heart Disease) 08/2022 - 08/2017
3	Anemia 11/2021 - 03/2016
3	Non-ST Elevated Myocardial Infarction 01/2021 - 08/2015
3	Neointima 11/2020 - 08/2006
3	Hyperemia 01/2020 - 07/2017
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 11/2014
3	Chest Pain (Chest Pains) 06/2016 - 11/2005
3	Atherosclerosis 02/2016 - 08/2005
3	Coronary Stenosis (Coronary Artery Stenosis) 05/2015 - 02/2007
3	Necrosis 05/2012 - 09/2008
3	Coronary Disease (Coronary Heart Disease) 05/2012 - 03/2005
2	Liver Diseases (Liver Disease) 11/2022 - 09/2002
2	Heart Arrest (Cardiac Arrest) 11/2022 - 10/2020
2	Peripheral Arterial Disease 01/2022 - 10/2016
2	Venous Thromboembolism 01/2022 - 04/2013
2	Renal Insufficiency (Renal Failure) 12/2021 - 09/2011
2	Out-of-Hospital Cardiac Arrest 02/2021 - 11/2020
2	Cardiac Arrhythmias (Arrythmia) 01/2021 - 02/2019
2	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2020 - 02/2017

Drug/Important Bio-Agent (IBA)

77	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2022 - 12/2011
49	MetalsIBA 10/2021 - 05/2004
42	omega-Chloroacetophenone (Mace)IBA 10/2022 - 05/2004
41	TicagrelorIBA 08/2022 - 08/2011
41	Clopidogrel (Plavix)FDA Link 01/2021 - 10/2005
35	Sirolimus (Rapamycin)FDA Link 01/2022 - 05/2004
33	Everolimus FDA Link 01/2022 - 12/2011
30	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2022 - 06/2004
28	bivalirudin (Angiomax)FDA Link 12/2021 - 02/2011
23	Tirofiban (Aggrastat)FDA Link 08/2022 - 05/2004
20	Pharmaceutical PreparationsIBA 01/2022 - 01/2005
20	Heparin (Liquaemin)FDA LinkGeneric 12/2021 - 07/2004
19	Prasugrel Hydrochloride FDA Link 08/2021 - 08/2011
17	AnticoagulantsIBA 01/2022 - 06/2014
15	PolymersIBA 01/2022 - 08/2014
15	Glycoproteins (Glycoprotein)IBA 02/2020 - 07/2004
13	ProdigyIBA 10/2017 - 11/2010
12	CreatinineIBA 11/2022 - 08/2005
12	Paclitaxel (Taxol)FDA LinkGeneric 06/2016 - 04/2005
12	Abciximab (ReoPro)FDA Link 04/2013 - 05/2004
9	Vitamin K FDA Link 01/2022 - 11/2014
9	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 06/2009
7	CobaltIBA 01/2021 - 12/2011
7	ChromiumIBA 01/2021 - 12/2011
7	zotarolimusIBA 02/2019 - 03/2013
6	edoxabanIBA 12/2021 - 01/2018
5	cangrelorIBA 07/2022 - 01/2020
5	Biomarkers (Surrogate Marker)IBA 01/2018 - 08/2005
5	Adenosine (Adenocard)FDA LinkGeneric 01/2018 - 07/2009
5	TroponinIBA 01/2018 - 02/2007
5	thienopyridineIBA 07/2015 - 07/2007
4	Platelet Membrane Glycoprotein IIbIBA 08/2022 - 07/2004
4	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 04/2012
4	Hemoglobins (Hemoglobin)IBA 12/2021 - 01/2020
4	Thrombin Receptors (Thrombin Receptor)IBA 03/2017 - 01/2012
3	Fentanyl (Sublimaze)FDA LinkGeneric 01/2022 - 01/2019
3	AntithrombinsIBA 12/2021 - 12/2014
3	N(4)-oleylcytosine arabinosideIBA 01/2021 - 12/2019
3	Insulin (Novolin)FDA Link 01/2019 - 08/2005
3	vorapaxarIBA 09/2014 - 01/2012
3	LipidsIBA 01/2007 - 03/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 03/2006
2	BESIBA 10/2020 - 06/2015
2	RivaroxabanIBA 01/2020 - 02/2017
2	Adenosine Diphosphate (ADP)IBA 01/2020 - 12/2006

Therapy/Procedure

202	Stents 11/2022 - 05/2004
168	Percutaneous Coronary Intervention 11/2022 - 03/2005
123	Therapeutics 11/2022 - 10/2005
64	Drug-Eluting Stents 01/2022 - 03/2005
17	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 07/2007
15	Duration of Therapy 12/2021 - 12/2014
13	Transcatheter Aortic Valve Replacement 10/2022 - 01/2015
9	Secondary Prevention 01/2022 - 11/2005
4	Myocardial Revascularization 03/2021 - 01/2013
3	Patient Readmission 07/2017 - 01/2012
2	Dual Anti-Platelet Therapy 07/2020 - 01/2019